Secondary Endpoints

Related by string. secondary endpoints * Secon dary . SECONDARY . secondary : Secondary Offering . secondary efficacy endpoints . Secondary School / EndPoint . endpoints . endpoint : primary efficacy endpoint . video conferencing endpoints . Endpoints * Secondary endpoints include . Secondary endpoints included . specified secondary endpoints . Key secondary endpoints *

Related by context. Frequent words. (Click for all words.) 70 Elderly Patients 69 Prostate Cancer Patients 68 Cholesterol Levels 68 Improves Survival 67 Study Demonstrates 67 Clinical Trial Results 67 Venous Thromboembolism 67 Patients Treated 66 Pediatric Patients 66 Phase III Trial 66 Single Dose 66 Postmenopausal Women 66 Monotherapy 66 Patient Enrollment 66 Heart Failure Patients 65 Renal Cell Carcinoma 65 Cardiovascular Events 65 Phase III Clinical Trial 65 Advanced Prostate Cancer 64 Patients Undergoing 64 Survival Rates 64 Preclinical Data 64 Pivotal Phase III 64 Lung Function 64 Diabetic Patients 64 Tolerability 64 Patient Outcomes 64 Prostate Cancer Risk 63 Cognitive Decline 63 Chronic Hepatitis B 63 Main Outcome Measures 63 Generalized Anxiety Disorder 63 Well Tolerated 63 Pivotal Study 62 Pivotal Phase 62 Significantly Reduces 62 Low Dose 62 Overactive Bladder 62 Metastatic Melanoma 62 Metastatic Colorectal Cancer 62 Allergic Rhinitis 62 Regimens 62 Drug Candidate 61 Significantly Improves 61 Blood Vessels 61 Immunogenicity 61 Reduces Risk 61 Atopic Dermatitis 61 Increases Risk 61 Pivotal Trial 61 Benign Prostatic Hyperplasia 60 Clinical Outcomes 60 Urinary Tract Infections 60 Chronic Hepatitis C 60 II Clinical Trial 60 Induces 60 Antipsychotic 60 Dialysis Patients 60 Radiation Exposure 60 Gene Mutation 60 Post Operative 60 Pulmonary Arterial Hypertension 60 Meta Analysis 60 Ischemic 60 Stroke Risk 60 C Reactive Protein 59 Tumor Growth 59 Medication Errors 59 Combination Therapy 59 Jobless Claims Drop 59 Brain Function 59 Acute Coronary Syndromes 59 Completes Enrollment 59 Solid Tumors 58 Enoxaparin 58 Jobless Claims Fall 58 FDA Clears 58 Increased Risk 58 Dyslipidemia 58 Angiographic 58 Extended Release 58 Presents Positive 58 Ear Infections 58 Early Diagnosis 58 Drug Eluting Stents 58 Anti TNF 58 Inhibits 57 Bioavailability 57 Natalizumab 57 Study Indicates 57 Blood Glucose 57 Recombinant Human 57 Acute Myocardial Infarction 57 Initiate Phase 57 Gender Differences 57 Regulatory Requirements 57 Virtual Colonoscopy 56 Potency 56 Reduce Risk 56 Monthly Dividends 56 Prophylaxis

Back to home page